Skip to main content
Have a personal or library account? Click to login
A phantom to assess the accuracy of tumor delineation using MRSI Cover

A phantom to assess the accuracy of tumor delineation using MRSI

Open Access
|Dec 2008

References

  1. Pallud J, Devaux B, Nataf F, Roux FX, Daumas-Duport C. Spatial delimitation of low grade oligodendrogliomas.2005;253-9.
  2. Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, et al. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.2004;126-37.
  3. Walecki J, Tarasow E, Kubas B, Czemicki Z, Lewko J, Podgorski J., et al. Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: assessment of the value of the method.2003;145-53.
  4. Chang J, Thakur S, Perera G, Kowalski A, Huang W, Karimi S., et al. Image-fusion of MR spectroscopic images for treatment planning of gliomas.2006;32-40.
  5. McKnight TR, Noworolski SM, Vigneron DB, Nelson SJ. An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma.2001;167-77.
  6. Hunjan S, Adalsteinsson E, Kim DH, Harsh GR, Boyer AL, Spielman D., et al. Quality assurance of magnetic resonance spectroscopic imaging-derived metabolic data.2003;1159-73.
  7. Woo DC, Kim BS, Jung SL, Park HJ, Rhim HS, Jahng GH., et al. Develpment of a cone-shaped phantom for multi-voxel MR scpectroscopy.2007;101-7.
  8. Rice JR, Milbrandt RH, Madsen EL, Frank GR, Boote EJ, Blenchinger JC. AnthromorphicH MRS head phantom.1998;1145-56.
  9. Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5T and 3.0T.2001;765-9.
  10. Drost DJ, Riddle WR, Clarke GD. Proton magnetic resonance spectroscopy in the brain: Report of AAPM Task Group #9.2002;2177-97.
  11. Nishimura DG.Stanford: Stanford University; 1996.
  12. Haacke EM.New York: John Wiley & Sons; 1999.
  13. Doddrell DM, Galloway G, Brooks W, Filed J, Bulsing J, Irving M, et al. Water signal elimination in vivo, using suppression by mistimed echo and repetitive gradient episodes.1986;176-80.
  14. Hasse A, Frahm J, Hanicke W, Mattaei W. 1H NMR chemical shift selective (CHESS) imaging.1985;341-4.
  15. Mierisova S, Ala-Korpela M. MR spectroscopy quantitation: a review of frequency domain methods.2001;247-59.
  16. Moré JJ.In: GA Watson, editor. Lecture notes in mathematics. Heidelberg: Springer Verlag; 1977. p. 105-16.
  17. Nelson SJ, Graves E, Pirzkall A, Li X, Chan AA, Vigneron DB., et al. In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI.2002;464-76.
  18. Narayana A, Chang J, Thakur S, Huang W, Karimi S, Hou B, et al. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas.2007;347-54.
  19. Jeun SS, Kim MC, Kim BS, Lee JM, Chung ST, Oh CH, et al. Assessment of malignancy in gliomas by 3T 1H MR spectroscopy.2005;10-5.
DOI: https://doi.org/10.2478/v10019-008-0015-3 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 232 - 239
Published on: Dec 29, 2008
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2008 Amr Heikal, Keith Wachowicz, Steven Thomas, Biagio Fallone, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.